These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3019572)

  • 21. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA type of EBV-transformed human B cell lines.
    Hurley CK; Johnson AH
    Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1G. PubMed ID: 18432643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M; Matej H; Duś D; Myc A
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
    J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of PPD-specific T-cell lines generated in type I (insulin-dependent) diabetic and healthy individuals.
    Mølvig J; Sønderstrup McDevitt G; Thomsen M; Bosmann B; Blangero C; de Preval C; Baek L; Nerup J
    Scand J Immunol; 1989 Nov; 30(5):615-29. PubMed ID: 2587937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell.
    van Els CA; Bakker A; van Rood JJ; Goulmy E
    Hum Immunol; 1990 May; 28(1):39-50. PubMed ID: 2160446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
    Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
    Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
    Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.
    Vigouroux S; Yvon E; Wagner HJ; Biagi E; Dotti G; Sili U; Lira C; Rooney CM; Brenner MK
    J Virol; 2003 Oct; 77(20):10872-80. PubMed ID: 14512537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative responses to a nonspecific factor produced by irradiated stimulating cells can simulate antigen-specific secondary responses in the primed lymphocyte test.
    Reitnauer PJ; Brown LR; Hank JA; Sondel PM
    J Immunol; 1983 Jul; 131(1):165-70. PubMed ID: 6190905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-D typing using Epstein-Barr virus-induced lymphoblastoid cell lines.
    Akiyama N; Ohsawa N; Samaru Y; Kusaba R
    Jpn J Exp Med; 1982 Apr; 52(2):67-73. PubMed ID: 6288983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells.
    Orsini DL; van Gils M; Kooy YM; Struyk L; Klein G; van den Elsen P; Koning F
    Eur J Immunol; 1994 Dec; 24(12):3199-204. PubMed ID: 7528674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
    Mori T; Koishi T; Fujii G; Ohsawa N
    Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of human cytotoxic T-cell lines specific for Epstein-Barr virus-transformed autologous cells.
    Sugamura K; Tanaka Y; Hinuma Y
    Int J Cancer; 1981 Aug; 28(2):137-42. PubMed ID: 6274810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
    Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
    J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.